1. Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. (3rd June 2018) Authors: Patel, Poulam M.; Ottensmeier, Christian H.; Mulatero, Clive; Lorigan, Paul; Plummer, Ruth; Pandha, Hardev; Elsheikh, Somaia; Hadjimichael, Efthymios; Villasanti, Naty; Adams, Sally E.; Cunnell, Michelle; Metheringham, Rachael L.; Brentville, Victoria A.; Machado, Lee; Daniels, Ian; Gijon, Mohame... Journal: Oncoimmunology Issue: Volume 7:Number 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗